Investing Profile
Samuel Bjork
Your Intro Paths to Samuel Bjork
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Samuel is a member of
Boston Consulting Group (BCG) Network
460 CONNECTIONS
Harvard University Network
146 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
Zinook Ltd. (Nasdaq: THCG Subsidiary) Network
45 CONNECTIONS
University of Cambridge Network
44 CONNECTIONS
Find Samuel Bjork on
cbCurrent Investing Position
Digitalis Ventures Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
10
Current Fund Size
$300M
Samuel Bjork is on these Sector & Stage Rankings
Samuel Bjork's Investments On Record (6)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
EpiBiologics | Series BJan 2026$110M Series AJul 2023$23M | $200M |
T-Therapeutics | Series ANov 2025$32M Series ANov 2023$60M | $92M |
Judo Bio Inc. | Series AOct 2024$75M | $75M |
Bonum Therapeutics | Series ANov 2022$93M | $93M |
Good Therapeutics | Series BDec 2021$8M Series AMay 2020$11M Series AFeb 2019$11M | $30M |
MollyBox | Series BMar 2019$13M | $13M |
Samuel Bjork's Experience
Researcher + Production Assistant Fourth Floor Productions (Office of Errol Morris)Present
Researcher + Production Assistant Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Laboratory Research Harvard UniversityPresent
Graduate Research Zinook Ltd. (Nasdaq: THCG Subsidiary)Present
Graduate Research University of CambridgePresent
Project Leader Boston Consulting Group (BCG)Present
Strategic Advisor Columbia Technology VenturesPresent
Partner Digitalis VenturesPresent
Investors who invest with Samuel Bjork
Sign in with Google →Scouts & Angels Affiliated With Samuel Bjork
Sign in with Google →